Kyverna Therapeutics

Developer of T-cell therapy for autoimmune disease

placeBerkeley, California, United States calendar_todayFounded 2018 groups96 employees language kyvernatx.com

Registered entities

Social engagement

Social engagement: 41.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

15 investors on record; lead investors include Bain Capital Life Sciences, GordonMD Global Investments, Northpond Ventures.

Investor typeCountShare
Venture capital853%
Private equity320%
Other / undisclosed427%

Hiring activity

Hires periodically

4 roles tracked across 3 of the last 12 months

7 May 2026 · Sr. Clinical Research Scientist · All India

15 Jan 2026 · Director, Quality Control · Emeryville

6 Nov 2025 · GL/AP Accounting Consultant (Contractor) · Chicago

6 Nov 2025 · Medical Writing Operations Manager (Contract) · San Diego

30 Aug 2025 · VP, Global Market Access · Emeryville

Based on job postings tracked across public sources.

Recent activity

30 Jun 2026
Event
European Academy of Neurology Congress 2026
22 Jun 2026
Leadership hire
Chief Legal and Compliance Officer
18 Jun 2026
Event
BIO2026 meeting
Coming soon